Presentation will include an update on the development and launch preparations of Cylembio™ (imsapepimut and etimupepimut, adjuvanted)NEW YORK, ...

In the past week, a Boston biotech led by longtime industry CEO Harvey Berger said it plans to shut down, while another ...

Another healthcare stock came across our desk during the mid-week session after it was announced that Piper Sandler initiated ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

Aurion Biotech, Inc. (Aurion), whose mission is to restore vision to millions of patients with life-changing regenerative ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The lawsuit, filed Monday in US District Court for Massachusetts, was co-led by Andrea Campbell and asserts that the Trump ...

A federal judge is set to hear arguments this week on the Trump administration's order to slash "indirect costs" for NIH ...

According to the report, it marks the largest layoff in the history of the organization — Massachusetts’ largest private ...